Table 8 ROC analysis for differentiating PAF patients from non-AF subjects with 3D STE derived parameters
Parameters | AUC(95%CI) | Cutoff value | Sensitivity(95%CI) | Specificity(95%CI) |
|---|---|---|---|---|
LAVImax(ml/m2) | 0.703 (0.627 ~ 0.780) | 27.8 | 61.9 (53.3 ~ 70.0) | 72.9 (59.7 ~ 83.6) |
LAVmin(ml) | 0.823 (0.762 ~ 0.884) | 21 | 86.3 (79.5 ~ 91.6) | 67.8 (54.4 ~ 79.4) |
LAEF(%) | 0.830 (0.770 ~ 0.891) | 46.5 | 69.8 (61.4 ~ 77.3) | 84.7 (73.0 ~ 92.8) |
pLAEF(%) | 0.639 (0.551 ~ 0.726) | 22.3 | 69.1 (60.7 ~ 76.6) | 57.6 (44.1 ~ 70.4) |
aLAEF(%) | 0.826 (0.768 ~ 0.884) | 33.7 | 69.1 (60.7 ~ 76.6) | 79.7 (67.2 ~ 89.0) |
LASr(%) | 0.758 (0.685 ~ 0.830) | 18 | 69.1 (60.7 ~ 76.6) | 72.9 (59.7 ~ 83.6) |
LASrc(%) | 0.850 (0.793 ~ 0.908) | 24 | 75.5 (67.5 ~ 82.4) | 81.4 (69.1 ~ 90.3) |
LAScd(%) | 0.635 (0.549 ~ 0.722) | −11 | 81.3 (73.8 ~ 87.4) | 42.4 (29.6 ~ 55.9) |
LAScdc(%) | 0.687 (0.602 ~ 0.772) | −9 | 65.5 (56.9 ~ 73.3) | 69.5 (56.1 ~ 80.8) |
LASct(%) | 0.741 (0.669 ~ 0.814) | −8.5 | 59.7 (51.1 ~ 67.9) | 79.7 (67.2 ~ 89.0) |
LASctc(%) | 0.828 (0.768 ~ 0.887) | −14 | 62.6 (54.0 ~ 70.6) | 86.4 (75.0 ~ 94.0) |